Gurgaon-based NirogStreet, a one of its kind technology-led Ayurveda platform, has raised $300,000 (~ Rs 2 Crore) in funding from Japanese venture fund Spiral Ventures.
Other investors who also participated in this round include Subho Ray, president of the Internet and Mobile Association of India (IAMAI) and Samir Kumar, Director of Derivatives at Deutsche Bank (Singapore).
The startup plans to use the capital raised for technological advancement of their platform dedicated to make Ayurveda the first call of treatment globally. The funds would also be used in spreading awareness and visibility about Ayurveda. Besides, the startup is looking to raise pre-series A funding in October 2018
Founded in 2016 by Ram Kumar, NirogStreet is an Ayurvedic doctor discovery and appointment booking platform where patients can easily find doctors and fix consultation. The startup is working towards building back the trust and preference for Ayurveda treatment and practitioners across the world by encouraging evidence-based practices.
Moreover, the startup is also said to be working closely with Ayurveda institutions and researchers to advance Ayurvedic research and collaboration with modern medical technologies, to make this ancient medical science more result-oriented and trusted.
NirogStreet, which has over 15,000 doctors engaged on its platform so far, allows sharing of expertise and opinion on treatments in real-time through its mobile app.
NirogStreet founder and CEO Ram N Kumar said: “Today western medicine backed by a cohesive marketing push is the primary choice of healthcare.
“On the other hand, Ayurveda, which is a thousands of years old Indian medicine system offering the safest and most effective treatment, is still waiting to gain its place as the preferred system in modern healthcare.”
Kumar added that there are over 5 lakh existing Ayurveda graduates and over 25,000 new graduates entering the field of Ayurveda every year.
“But quality care, updated knowledge, and access to medicine is a challenge. NirogStreet is a platform where doctors can interact with each other, share knowledge and buy high-quality medicines,” he said.
Source: Times of India